JPWO2019165148A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019165148A5 JPWO2019165148A5 JP2020544212A JP2020544212A JPWO2019165148A5 JP WO2019165148 A5 JPWO2019165148 A5 JP WO2019165148A5 JP 2020544212 A JP2020544212 A JP 2020544212A JP 2020544212 A JP2020544212 A JP 2020544212A JP WO2019165148 A5 JPWO2019165148 A5 JP WO2019165148A5
- Authority
- JP
- Japan
- Prior art keywords
- proteins
- stationary phase
- protein
- yield
- purity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862633584P | 2018-02-21 | 2018-02-21 | |
| US62/633,584 | 2018-02-21 | ||
| PCT/US2019/019050 WO2019165148A1 (en) | 2018-02-21 | 2019-02-21 | Determining conditions for purification of proteins |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021521412A JP2021521412A (ja) | 2021-08-26 |
| JP2021521412A5 JP2021521412A5 (https=) | 2022-03-02 |
| JPWO2019165148A5 true JPWO2019165148A5 (https=) | 2022-03-02 |
| JP7332610B2 JP7332610B2 (ja) | 2023-08-23 |
Family
ID=65763767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544212A Active JP7332610B2 (ja) | 2018-02-21 | 2019-02-21 | タンパク質の精製条件の決定 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20200408728A1 (https=) |
| EP (2) | EP3755447B1 (https=) |
| JP (1) | JP7332610B2 (https=) |
| CA (1) | CA3091905C (https=) |
| ES (1) | ES2978413T3 (https=) |
| WO (1) | WO2019165148A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY204234A (en) | 2018-08-27 | 2024-08-16 | Regeneron Pharma | Use of raman spectroscopy in downstream purification |
| MX2022013313A (es) * | 2020-04-23 | 2022-11-30 | Amgen Inc | Seleccion de parametros de cromatografia para la fabricacion de proteinas terapeuticas. |
| CA3195893A1 (en) * | 2020-09-21 | 2022-03-24 | Bayer Healthcare Llc | Pathogen clearance system and method |
| WO2025064403A2 (en) * | 2023-09-18 | 2025-03-27 | Regeneron Pharmaceuticals, Inc. | Methods and systems for developing chromatography protocols |
| CN121075496B (zh) * | 2025-11-05 | 2026-03-27 | 鲁东大学 | 一种基于特征工程与集成学习的蛋白质盐敏感性预测方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020010566A1 (en) * | 2000-04-11 | 2002-01-24 | Chester Thomas Lee | Methods for modeling, predicting, and optimizing high performance liquid chromatography parameters |
| US20040034477A1 (en) * | 2002-08-19 | 2004-02-19 | Mcbrien Michael | Methods for modeling chromatographic variables |
| EP1539321A1 (de) * | 2002-09-19 | 2005-06-15 | MERCK PATENT GmbH | Verfahren zum auffinden geeigneter chromatographiebedingungen zur trennung biologischer moleküle |
| DE102006027496B3 (de) * | 2006-06-14 | 2008-01-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Optimierung chromatographischer Reinigungsverfahren für Biomoleküle |
| US11460455B2 (en) * | 2014-11-12 | 2022-10-04 | Cytiva Sweden Ab | Method and system for determining the influence of experimental parameters on a liquid chromatography protocol |
| GB2539420B (en) * | 2015-06-16 | 2021-01-13 | Cytiva Sweden Ab | Determination of chromatography conditions |
-
2019
- 2019-02-21 JP JP2020544212A patent/JP7332610B2/ja active Active
- 2019-02-21 ES ES19710843T patent/ES2978413T3/es active Active
- 2019-02-21 EP EP19710843.4A patent/EP3755447B1/en active Active
- 2019-02-21 WO PCT/US2019/019050 patent/WO2019165148A1/en not_active Ceased
- 2019-02-21 EP EP24161128.4A patent/EP4372376B1/en active Active
- 2019-02-21 US US16/969,522 patent/US20200408728A1/en active Pending
- 2019-02-21 CA CA3091905A patent/CA3091905C/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Timms et al. | Difference gel electrophoresis | |
| JP2021521412A5 (https=) | ||
| Dowling et al. | Fiber-type shifting in sarcopenia of old age: proteomic profiling of the contractile apparatus of skeletal muscles | |
| Lame et al. | Quantitation of amyloid beta peptides Aβ1–38, Aβ1–40, and Aβ1–42 in human cerebrospinal fluid by ultra-performance liquid chromatography–tandem mass spectrometry | |
| Zvereva et al. | Enzyme immunoassay and proteomic characterization of troponin I as a marker of mammalian muscle compounds in raw meat and some meat products | |
| Qian et al. | Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach | |
| CN103134938B (zh) | 适体在蛋白质组学中的用途 | |
| EP3406721B1 (en) | Method for screening nucleic acid aptamer | |
| Athar et al. | RNA-binding specificity of the human fragile X mental retardation protein | |
| Caplow et al. | Dissociation of the tubulin dimer is extremely slow, thermodynamically very unfavorable, and reversible in the absence of an energy source | |
| US20130137117A1 (en) | Method for preparing protein imprinted polymers and use thereof | |
| JP2016536598A (ja) | 神経疾患のバイオマーカーを同定するための方法および神経疾患の診断 | |
| JP7332610B2 (ja) | タンパク質の精製条件の決定 | |
| Smith et al. | Calibrated Langevin-dynamics simulations of intrinsically disordered proteins | |
| Herosimczyk et al. | Plasma proteome analysis: 2D geld and chips | |
| Wiederkehr et al. | Two-dimensional gel electrophoresis of cerebrospinal fluid proteins from patients with various neurological diseases. | |
| JPWO2019165148A5 (https=) | ||
| US20230160913A1 (en) | Method for diagnosing a condition characterized by tdp-43 proteinopathy | |
| NL2023825B1 (en) | Single-molecule FRET for protein characterization | |
| CN112813070A (zh) | 结合河豚毒素的高亲和性核酸适配体及其获得方法和用途 | |
| US20110011742A1 (en) | Method for the purification of biological macromolecules | |
| Diez et al. | 2-D fluorescence difference gel electrophoresis (DIGE) in neuroproteomics | |
| Dowling et al. | Proteomic reference map for sarcopenia research: mass spectrometric identification of key muscle proteins located in the sarcomere, cytoskeleton and the extracellular matrix | |
| WO2017032848A1 (en) | Method for determining affinity of a biomolecule | |
| Di Domenico et al. | Redox proteomics in human biofluids: sample preparation, separation and immunochemical tagging for analysis of protein oxidation |